Suppr超能文献

欧洲癌症研究与治疗组织22921试验中纳入的95例直肠癌患者的形态学特征和分子标志物:术前放疗(化疗)的预后价值及影响

Morphological features and molecular markers in rectal cancer from 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 trial: prognostic value and effects of preoperative radio (chemo) therapy.

作者信息

Debucquoy Annelies, Libbrecht Louis, Roobrouck Valerie, Goethals Laurence, McBride William, Haustermans Karin

机构信息

Department of Radiation Oncology, Leuven Cancer Institute, University Hospital Leuven, Belgium.

出版信息

Eur J Cancer. 2008 Apr;44(6):791-7. doi: 10.1016/j.ejca.2008.02.023. Epub 2008 Mar 18.

Abstract

In this study, the prognostic and/or predictive value of different proteins (cyclo-oxygenase 2 (COX-2), Ki67 and cleaved cytokeratin (CK) 18) and fibro-inflammatory changes which might be of importance for the response to treatment were evaluated using tissue micro arrays. Samples were obtained from a subset of 95 patients included in the European Organisation for Research and Treatment of Cancer 22921 clinical trial, which randomised patients with rectal cancer to one of four arms treated with preoperative radiotherapy with or without pre- and/or postoperative chemotherapy. From our results, we can conclude that the addition of preoperative chemotherapy to radiotherapy led to significantly less COX-2 upregulation, less proliferation and more inflammation, as was seen in the resection specimen as well as less invasion and metastasis. For COX-2, Ki67 or cleaved CK18, no predictive or prognostic value could be identified. However, the fibro-inflammatory reaction after preoperative radiochemotherapy correlated with T-downstaging and seems to be an important factor for response.

摘要

在本研究中,使用组织微阵列评估了不同蛋白质(环氧化酶2(COX-2)、Ki67和裂解细胞角蛋白(CK)18)的预后和/或预测价值,以及可能对治疗反应具有重要意义的纤维炎症变化。样本取自欧洲癌症研究与治疗组织22921临床试验中纳入的95例患者的一个子集,该试验将直肠癌患者随机分为四个治疗组之一,接受术前放疗加或不加术前和/或术后化疗。从我们的结果可以得出结论,放疗联合术前化疗导致COX-2上调显著减少、增殖减少、炎症增加,这在切除标本中也有体现,同时侵袭和转移减少。对于COX-2、Ki67或裂解CK18,未发现有预测或预后价值。然而,术前放化疗后的纤维炎症反应与肿瘤降期相关,似乎是反应的一个重要因素。

相似文献

2
Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study.
Int J Colorectal Dis. 2009 Feb;24(2):129-38. doi: 10.1007/s00384-008-0608-8. Epub 2008 Dec 3.
3
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: a phase II TCOG study.
J Surg Oncol. 2014 May;109(6):580-5. doi: 10.1002/jso.23538. Epub 2013 Dec 24.
5
Molecular responses of rectal cancer to preoperative chemoradiation.
Radiother Oncol. 2006 Aug;80(2):172-7. doi: 10.1016/j.radonc.2006.07.016. Epub 2006 Aug 14.
6
Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
J Clin Oncol. 2003 Sep 15;21(18):3391-401. doi: 10.1200/JCO.2003.07.077. Epub 2003 Jul 28.

引用本文的文献

3
Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications.
Biomed Res Int. 2015;2015:574540. doi: 10.1155/2015/574540. Epub 2015 Oct 5.
4
Prognostic value of tumor shrinkage versus fragmentation following radiochemotherapy and surgery for rectal cancer.
Virchows Arch. 2015 May;466(5):517-23. doi: 10.1007/s00428-015-1723-x. Epub 2015 Feb 19.
5
Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy.
Cancers (Basel). 2011 Apr 26;3(2):2176-94. doi: 10.3390/cancers3022176.
6
Gene expression analysis in chronic postradiation proctopathy.
Int J Colorectal Dis. 2012 Jul;27(7):879-84. doi: 10.1007/s00384-011-1387-1. Epub 2011 Dec 16.
7
Preoperative intensified radiochemotherapy for rectal cancer: experience of a single institution.
Int J Colorectal Dis. 2011 Feb;26(2):153-64. doi: 10.1007/s00384-010-1064-9. Epub 2010 Nov 25.
8
Links between innate immunity and normal tissue radiobiology.
Radiat Res. 2010 Apr;173(4):406-17. doi: 10.1667/RR1931.1.
9
The effect of cyclooxygenase-2 expression on tumor volume response in patients treated with radiotherapy for uterine cervical cancer.
J Korean Med Sci. 2009 Dec;24(6):1170-6. doi: 10.3346/jkms.2009.24.6.1170. Epub 2009 Nov 9.

本文引用的文献

2
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Science. 2006 Sep 29;313(5795):1960-4. doi: 10.1126/science.1129139.
3
Chemotherapy with preoperative radiotherapy in rectal cancer.
N Engl J Med. 2006 Sep 14;355(11):1114-23. doi: 10.1056/NEJMoa060829.
4
Molecular responses of rectal cancer to preoperative chemoradiation.
Radiother Oncol. 2006 Aug;80(2):172-7. doi: 10.1016/j.radonc.2006.07.016. Epub 2006 Aug 14.
6
Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.
Virchows Arch. 2006 Apr;448(4):442-8. doi: 10.1007/s00428-005-0137-6. Epub 2005 Dec 20.
7
Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer.
Am J Clin Oncol. 2005 Dec;28(6):560-4. doi: 10.1097/01.coc.0000182476.34375.17.
8
COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy.
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):466-72. doi: 10.1016/j.ijrobp.2005.07.961. Epub 2005 Oct 5.
9
Chemoradiotherapy for rectal cancer: current status and perspectives.
Int J Clin Oncol. 2004 Dec;9(6):475-83. doi: 10.1007/s10147-004-0459-4.
10
COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Crit Rev Oncol Hematol. 2004 Nov;52(2):81-101. doi: 10.1016/j.critrevonc.2004.08.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验